T. Rowe Price Associates’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$680K	Sell	547,965 -37,763	-6%	-$46.9K	﹤0.01%	2156
2025 Q1	$716K	Sell	585,728 -42,922	-7%	-$52.5K	﹤0.01%	2110
2024 Q4	$1.13M	Sell	628,650 -43,916	-7%	-$79.1K	﹤0.01%	1904
2024 Q3	$3.43M	Buy	+672,566	New	+$3.43M	﹤0.01%	1413